Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
OPKO Health Inc is a diagnostics & research business based in the US. OPKO Health shares (OPK) are listed on the NASDAQ and all prices are listed in US Dollars. OPKO Health employs 5,269 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $3.01 |
|---|---|
| 52-week range | $3.26 - $6.27 |
| 50-day moving average | $4.32 |
| 200-day moving average | $3.93 |
| Wall St. target price | $6.90 |
| PE ratio | 35.9322 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $0.12 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.01 from 2022-01-25
| 1 week (2022-01-19) | -32.05% |
|---|---|
| 1 month (2021-12-23) | -36.90% |
| 3 months (2021-10-26) | -16.39% |
| 6 months (2021-07-26) | -15.69% |
| 1 year (2021-01-26) | -42.78% |
|---|---|
| 2 years (2020-01-24) | 90.51% |
| 3 years (2019-01-25) | 3.81 |
| 5 years (2017-01-26) | 8.72 |
Valuing OPKO Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPKO Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
OPKO Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, OPKO Health shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
OPKO Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $178.6 million.
The EBITDA is a measure of a OPKO Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.9 billion |
|---|---|
| Operating margin TTM | 5.3% |
| Gross profit TTM | $465.7 million |
| Return on assets TTM | 2.58% |
| Return on equity TTM | 4.48% |
| Profit margin | 4.06% |
| Book value | $2.59 |
| Market capitalisation | $2.9 billion |
TTM: trailing 12 months
We're not expecting OPKO Health to pay a dividend over the next 12 months.
Over the last 12 months, OPKO Health's shares have ranged in value from as little as $3.26 up to $6.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPKO Health's is 1.7319. This would suggest that OPKO Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico.
Bitcoin breached the $40,000 price level and may plummet lower as Russia signals a potential ban.
Cardano’s first metaverse project is available to investors now — if you can find a piece of digital land on sale. Plots sold fast despite the project’s early stage limitations.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
